These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23556511)

  • 1. Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP.
    Babin C; Majeau N; Leclerc D
    J Nanobiotechnology; 2013 Apr; 11():10. PubMed ID: 23556511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of papaya mosaic virus (PapMV) nanoparticles through fusion of the HA11 peptide to several putative surface-exposed sites.
    Rioux G; Babin C; Majeau N; Leclerc D
    PLoS One; 2012; 7(2):e31925. PubMed ID: 22363771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling.
    Thérien A; Bédard M; Carignan D; Rioux G; Gauthier-Landry L; Laliberté-Gagné MÈ; Bolduc M; Savard P; Leclerc D
    J Nanobiotechnology; 2017 Jul; 15(1):54. PubMed ID: 28720097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity.
    Laliberté-Gagné ME; Bolduc M; Garneau C; Olivera-Ugarte SM; Savard P; Leclerc D
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33435570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP].
    Savard C; Laliberté-Gagné MÈ; Babin C; Bolduc M; Guérin A; Drouin K; Forget MA; Majeau N; Lapointe R; Leclerc D
    Vaccine; 2012 Mar; 30(15):2535-42. PubMed ID: 22326774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform.
    Denis J; Acosta-Ramirez E; Zhao Y; Hamelin ME; Koukavica I; Baz M; Abed Y; Savard C; Pare C; Lopez Macias C; Boivin G; Leclerc D
    Vaccine; 2008 Jun; 26(27-28):3395-403. PubMed ID: 18511159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine.
    Carignan D; Thérien A; Rioux G; Paquet G; Gagné ML; Bolduc M; Savard P; Leclerc D
    Vaccine; 2015 Dec; 33(51):7245-7253. PubMed ID: 26549362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine.
    Rioux G; Carignan D; Russell A; Bolduc M; Gagné MÈ; Savard P; Leclerc D
    J Nanobiotechnology; 2016 Jun; 14(1):43. PubMed ID: 27282291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine Platform.
    Laliberté-Gagné MÈ; Bolduc M; Thérien A; Garneau C; Casault P; Savard P; Estaquier J; Leclerc D
    Vaccines (Basel); 2019 Jun; 7(2):. PubMed ID: 31212772
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticles.
    Savard C; Guérin A; Drouin K; Bolduc M; Laliberté-Gagné ME; Dumas MC; Majeau N; Leclerc D
    PLoS One; 2011; 6(6):e21522. PubMed ID: 21747909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization.
    Denis J; Majeau N; Acosta-Ramirez E; Savard C; Bedard MC; Simard S; Lecours K; Bolduc M; Pare C; Willems B; Shoukry N; Tessier P; Lacasse P; Lamarre A; Lapointe R; Lopez Macias C; Leclerc D
    Virology; 2007 Jun; 363(1):59-68. PubMed ID: 17320136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a cytotoxic T-cell epitope on the recombinant nucleocapsid proteins of Rinderpest and Peste des petits ruminants viruses presented as assembled nucleocapsids.
    Mitra-Kaushik S; Nayak R; Shaila MS
    Virology; 2001 Jan; 279(1):210-20. PubMed ID: 11145903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes.
    Fomsgaard A; Nielsen HV; Kirkby N; Bryder K; Corbet S; Nielsen C; Hinkula J; Buus S
    Vaccine; 1999 Nov; 18(7-8):681-91. PubMed ID: 10547428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagy.
    Possamaï D; Hanafi LA; Bellemare-Pelletier A; Hamelin K; Thébault P; Hébert MJ; Gagnon É; Leclerc D; Lapointe R
    PLoS One; 2021; 16(12):e0261987. PubMed ID: 34972158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells.
    Leclerc D; Beauseigle D; Denis J; Morin H; Paré C; Lamarre A; Lapointe R
    J Virol; 2007 Feb; 81(3):1319-26. PubMed ID: 17121795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiating Cancer Immunotherapy Using Papaya Mosaic Virus-Derived Nanoparticles.
    Lebel MÈ; Chartrand K; Tarrab E; Savard P; Leclerc D; Lamarre A
    Nano Lett; 2016 Mar; 16(3):1826-32. PubMed ID: 26891174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the coat protein of the flexible filamentous papaya mosaic virus.
    Yang S; Wang T; Bohon J; Gagné MÈ; Bolduc M; Leclerc D; Li H
    J Mol Biol; 2012 Sep; 422(2):263-73. PubMed ID: 22659319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.
    Lawson CM; Bennink JR; Restifo NP; Yewdell JW; Murphy BR
    J Virol; 1994 Jun; 68(6):3505-11. PubMed ID: 7514677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of neutralizing antibodies produced by papaya mosaic virus nanoparticles fused to the E2EP3 peptide epitope of Chikungunya envelope.
    Nor Rashid N; Teoh TC; Al-Harbi SJ; Yusof R; Rothan HA
    Trop Biomed; 2021 Mar; 38(1):36-41. PubMed ID: 33797522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.
    Bolduc M; Baz M; Laliberté-Gagné MÈ; Carignan D; Garneau C; Russel A; Boivin G; Savard P; Leclerc D
    Nanomedicine; 2018 Nov; 14(8):2563-2574. PubMed ID: 30193813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.